US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 19.980
  • -0.230-1.14%
Close Jul 23 16:00 ET
  • 20.160
  • +0.180+0.90%
Post 17:43 ET
929.99MMarket Cap13.23P/E (TTM)

Pacira BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pacira BioSciences Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Jul 30, 2024

Revenue(YoY)

173.66M

+2.48%
EPS(YoY)

0.31

-39.71%
Analyst Rating

Strong Buy

Jul 15, 2024

Pacira BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 170.974M--
Jul 30, 20242024/Q2-- / 173.662M--
May 7, 20242024/Q1167.117M / 165.670M--
Feb 29, 20242023/Q4181.244M / 180.825M--
Nov 2, 20232023/Q3163.926M / 172.927M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 170.974M--
Jul 30, 20242024/Q2-- / 173.662M--
May 7, 20242024/Q1167.117M / 165.670M--
Feb 29, 20242023/Q4181.244M / 180.825M--
Nov 2, 20232023/Q3163.926M / 172.927M--

Unlock Free Earnings Estimates

Pacira BioSciences Earnings Reports

  • Pacira BioSciences | 10-Q: Quarterly report

    May 7 16:07 ET

  • Pacira BioSciences | 10-K: Annual report

    Feb 29 15:39 ET

  • Pacira BioSciences | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 14:59 ET

  • Pacira BioSciences | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 14:47 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 15, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg